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Simple Summary: Actinic keratoses (AKs) are extremely common in the elderly population; they
are universally recognized as precursors of invasive squamous cell carcinoma, and their risk of
progression relates to the basal growth pattern of keratinocytes in the histological slides, based on
a model called “PRO” classification. Since AKs can be investigated at bedside with non-invasive
devices such the new line-field confocal optical coherence tomography (LC-OCT), we hypothesized
that it was also possible to use such devices for reproducing the PRO classification and assessing the
progression risk of AK without an invasive biopsy. In this pilot study, we demonstrated the feasibility
of the LC-OCT severity grading of AKs based on the histological PRO classification, obtaining a good
correlation between the two models and strong interobserver agreement.
Abstract: It is known that actinic keratoses (AKs) can progress to invasive squamous cell carcinoma
(SCC). The histological PRO grading of AKs is based on the growth pattern of basal keratinocytes
and relates to their progression risk. AKs can be non-invasively characterized by line-field confocal
optical coherence tomography (LC-OCT). The aim of the study was to define criteria for an LC-OCT
grading of AKs based on the PRO classification and to correlate it with its histological counterpart.
To evaluate the interobserver agreement for the LC-OCT PRO classification, fifty AKs were imaged
by LC-OCT and biopsied for histopathology. PRO histological grading was assessed by an expert
consensus, while two evaluator groups separately performed LC-OCT grading on vertical sections.
The agreement between LC-OCT and histological PRO grading was 75% for all lesions (weighted
kappa 0.66, 95% CI 0.48–0.83, p ≤ 0.001) and 85.4% when comparing the subgroups PRO I vs. PRO
II/III (weighted kappa 0.64, 95% CI 0.40–0.88, p ≤ 0.001). The interobserver agreement for LC-OCT
was 90% (Cohen’s kappa 0.84, 95% CI 0.71–0.91, p ≤ 0.001). In this pilot study, we demonstrated that
LC-OCT is potentially able to classify AKs based on the basal growth pattern of keratinocytes, in-vivo
reproducing the PRO classification, with strong interobserver agreement and a good correlation with
histopathology.
Keywords: actinic keratosis; PRO; dysplasia; keratinocyte cancer; field cancerization; line-field
confocal optical coherence tomography; bedside histology; skin imaging; non-invasive diagnostics
in dermatology
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1. Introduction
Actinic keratoses (AKs) or solar keratoses are scaly, pink to reddish brown macules
appearing as single to multiple elements on sun-exposed areas of elderly patients’ skin.
Clinically, AKs are divided into three main categories, from slightly palpable, to moderately
thick, to hyperkeratotic [1].
Originally described as keratoma senilis, they were renamed by Hermann Pinkus,
who combined their keratotic texture and their relationship with sunlight exposure [2].
Scalp, face, ears, neck, forearms and dorsal hands are the most involved body sites; males
are more often affected than females [3]. In addition to UV radiation, other risk factors
include fair skin, advanced age and chronic immunosuppression [4,5].
AKs are at risk of progressing to invasive squamous cell carcinoma (SCC) [6–11]. In
fact, AKs and SCC share overlapping cytological features (atypical keratinocytes, loss of
polarity, nuclear pleomorphism, altered maturation, higher mitotic index), which probably
express the continuum of DNA damage due to chronic sun exposure, leading to the
concept of field cancerization [12–15]. By definition, dysplastic alterations in AKs have
to be confined to foci within the epidermis, while tumor strands invading the dermo-
epidermal junction (DEJ) characterize invasive SCCs [16,17]. The most common histological
classification divides AKs into three subgroups based on the distribution of the atypical
keratinocytes within the epidermis, from the lower third (AK I), to two-thirds (AK II), to full
thickness atypia (AK III) [9]. Surprisingly, this model does not correlate with progression
to SCC, since the highest risk for invasion is instead associated with AKs with atypical
keratinocytes restricted to the lower epidermis third (AK I). Recent studies observed
that advanced basal proliferation of keratinocytes was related to progression to invasive
SCC [18,19]. For this reason, a new AK histopathological classification focused on the basal
growth pattern of keratinocytes was developed; the model was named “PRO I-III”, since it
was focused on different stages of downward extension of basal keratinocytes, “protruding”
into the papillary dermis. The earlier stage PRO I was characterized by the “crowding” of
atypical keratinocytes in the basal layer, PRO II by their “budding” in round nests into the
upper papillary dermis and PRO III by the “papillary sprouting”, with spikes of atypical
keratinocytes protruding into the dermis and thicker than the overlying epidermis [19–21].
Multiple AKs often arise on sun-damaged and elderly skin, in the context of a field
cancerization. Since it is not possible to predict which AKs will undergo progression into
SCC through clinical examination, the whole field cancerization should be treated [22]
Non-invasive diagnostic technologies such as reflectance confocal microscopy (RCM),
optical coherence tomography (OCT) and line-field confocal optical coherence tomography
(LC-OCT) have been successfully used to enhance the diagnostic accuracy of AKs and to
characterize the field cancerization in vivo [12,23–25].
As LC-OCT provides a cellular resolution, we hypothesized that it should be possible
to in-vivo grade the basal growth pattern of AKs based on LC-OCT images. The aim
of this study was to evaluate the agreement between the LC-OCT and histological PRO
classification of AKs. A secondary aim was to assess the interobserver agreement in
performing the LC-OCT PRO grading.
2. Materials and Methods
Fifty histologically confirmed AKs of the face, imaged with LC-OCT between January
2020 and 2021 at the Departments of Dermatology of the universities of Munich and
Augsburg, were analyzed in the study. The lesions belonged to 26 males and 17 females,
mean age 73.8 years (CI 57;86); we included the first sequentially recruited fifty lesions
with a histologically confirmed diagnosis of AK and a complete set of evaluable LC-
OCT images and histopathological slides. Previously treated and/or not histologically
confirmed lesions were excluded a priori from the analysis. During the selection process,
5 additional histologically confirmed AKs were excluded before performing the evaluation
and were therefore not included in the panel of the fifty lesions since the quality of LC-
OCT acquisition was not sufficient to analyze the required parameters (availability of only
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horizontal sections and not of vertical sections, artefacts such as oil bubbles). The whole
lesion was imaged and analyzed with multiple LC-OCT scans, examining the epidermis,
the DEJ and the dermis from the skin surface to a depth of approximately 500 µm. LC-OCT
images sized 1.2 × 0.5 mm2 were acquired with a prototype device (DAMAE Medical,
Paris), a class 1 supercontinuum laser with a central wavelength of 800 nm. Instrument
and acquisition procedures have been described elsewhere [26,27]. Image acquisition
was within a time frame of 0–7 days before the biopsy. The histologic specimens were 34
deep shave biopsies (with scalpel), 10 punch biopsies, 2 curettages (deep shave with ring
curette) and 4 excisions. They were included in paraffin and stained with hematoxylin
& eosin (H&E), according to the standard procedures, and evaluated as in daily routine
examinations. Only completely evaluable tissue specimens with a vertical orientation were
examined in the study.
We considered an H&E stained histological slide the gold standard. We did not per-
form any supplementary analysis with additional devices. PRO classification was made on
both histological slides and LC-OCT vertical images based on the criteria of the original
study by Schmitz et al. [21]: PRO I was defined by atypical keratinocytes crowded at basal
epidermal layers (crowding), PRO II showed a slight protrusion into the upper papillary
dermis with round nests of atypical keratinocytes (budding), thinner than the overlying
epidermis, and PRO III displayed spikes of atypical cells thicker than the overlying epider-
mis (papillary sprouting). In the event that two or more patterns were present in the same
image set, the higher score was chosen according to the literature [20,21]. LC-OCT images
in vertical mode were evaluated, blinded to H&E slides, by a pair of dermatologists expert
in non-invasive diagnostic techniques (observer round) and, separately, by a board-certified
dermatopathologist/dermatologist and a dermatologist educated in dermopathology, both
experts in non-invasive diagnostic techniques (consensus round). In case of discrepancy
regarding the grading, the dermatopathologist set the final decision, being the most experi-
enced in the PRO classification. Hematoxylin & Eosin (H&E) stained slides were evaluated
in a consensus by a board-certified dermatopathologist expert in both classification systems
and a dermatologist educated in dermatopathology, blinded to LC-OCT images. Since the
PRO classification was performed on histological slides in standard vertical sections, only
vertical LC-OCT images were examined, while horizontal sections were not analyzed in
order to avoid confounders and bias.
Cohen’s weighted kappa coefficient with linear weights was used to calculate the cor-
relation between LC-OCT and histopathological PRO score including confidence intervals
(CI); the two cases labeled as indefinable with LC-OCT were excluded from the analysis.
The correlation was also estimated into the different subgroups (PRO I and II/III). The
interobserver agreement was calculated with Cohen´s kappa coefficient, also taking into
account the non-definable cases. A p-value lower than 0.05 was considered significant [28].




Seventeen AKs were histologically classified as PRO I, 22 as PRO II and 11 as PRO
III. LC-OCT PRO grading was defined as in Figure 1. The LC-OCT PRO grading was in
agreement with the histological grading in 75% of the observations. The weighted kappa
for LC-OCT and histological classification was 0.66 (95% CI 0.48 to 0.83; p ≤ 0.001). Two
cases were not classifiable with LC-OCT due to excessive lesion thickness. Discordant cases
were either underestimated (12%) or overestimated (12%) (Table S1, Figure 2).
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Figure 1. Example of three AK lesions in LC-OCT (A,C,E) and histology (B,D,F) in H&E sections, 
original magnification 40×. (A,B). AK PRO I shows basal crowding of keratinocytes in an otherwise 
regularly layered epidermis, with no protrusions into the dermis. (C,D). AK PRO II displays spikes 
of atypical keratinocytes slightly protruding into the papillary dermis. (E,F). AK PRO III shows the 








Figure 1. Example of three AK lesions in LC-OCT (A,C,E) and histology (B,D,F) in H&E sections,
original magnification 40×. (A,B). AK PRO I shows basal crowding of keratinocytes in an otherwise
regul rly layered epidermis, with no protrusions into the dermis. (C,D). AK PRO II displays spikes
of atypical keratinocytes slightly protruding into the papillary dermis. (E,F). AK PRO III shows
the extended downward growth of atypical keratinocytes with spikes thicker than the overlying
epidermis.
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Figure 2. Example of AK lesion with discordant PRO grading between LC-OCT (A) and histology 
(40×, B): the hypertrophic AK on the scalp of an 85-year-old male patient was graded PROII in LC-
OCT and PROIII in H&E, probably because of the diffuse hyperkeratoses impeding the evaluation 
of the deepest layers of the lesions. 
If we take into account the subgroups, the agreement between LC-OCT and histology 
was 66.7% for PRO I, 86.5% for PRO II and 64% for PRO III. In the comparison between 
PRO I and PRO II-III grouped together as the higher progression risk category, the overall 
concordance was 85.4% (weighted kappa = 0.64, 95% CI, 0.40 to 0.88; p ≤ 0.001) (Figure 3). 
 
Figure 3. Overall (A) and subgroup (B) correlation between LC-OCT and histopathological PRO grading of AKs. ND: not 
definable. 
3.2. Agreement 
The interobserver agreement for LC-OCT PRO grading between the observer round 
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4. Discussion 
AKs are one of the most common skin conditions in the elderly population, mainly 
arising on sun-exposed areas of the skin in the context of a field cancerization. Following 
the current guidelines, all AKs should be treated, since it is not possible to predict which 
ones will grow into an invasive SCC [29]. The type of treatment should be determined 
based on the clinical features, the patients’ comorbidities and the previous therapies. Var-
ious local and field treatments, including surgery, laser ablation, photodynamic therapy 
and diverse topical treatments such as 5-fluorouracile, diclofenac, imiquimod and potas-
sium hydroxide, can be used. It is known that diagnosis and follow-up of AKs can be 
improved by non-invasive diagnostic technologies such as RCM, OCT and LC-OCT, 
which provide a painless bedside examination of keratinocyte cancer (KC) [12,15,24,25,30–
33]. RCM has been used for grading increasing keratinocyte dysplasia into different levels, 
with good correlation with histopathology, but it does not refer to specific classification 
systems [23]. 
We therefore focused on the in-vivo evaluation of the growth pattern of basal 
keratinocytes through LC-OCT, based on the recent PRO classification. The latter proved, 
in fact, to ensure the best interobserver agreement and the best risk stratification (in terms 
of progression risk to SCC) compared to other AK classifications [19–21]. We chose to use 
LC-OCT since it delivers dermoscopy-guided and real-time cross-sectional imaging of 
skin lesions with cellular resolution, so that the cytological and architectural features of 
the epidermis can be displayed in real time. It can visualize the epidermal layers, the DEJ 
and the superficial dermis, and its vertical acquisitions can be intuitively compared to 
histological slides [30,34,35]. Moreover, additional features such as perifollicular prolifer-
ation and adnexal extension can be visible, up to a depth of 500 μm. A direct and practical 
consequence is the potential in-vivo assessment of AK progression risk, since PRO III AKs 
are associated with a higher risk of developing an invasive SCC compared to PRO I [19–
21]. 
In our study, we were able to visualize and grade the downward extension of AKs 
non-invasively through LC-OCT, defining key imaging patterns that can be used as refer-
ence images. We reported strong interobserver agreement in grading the basal growth 
pattern of keratinocytes in the examined AKs. Moreover, we reported good agreement in 
the PRO classification of AKs between LC-OCT and traditional histopathology. Addition-
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and the subgroup of PRO II/III AKs, which are the lesions at higher risk of progression to 
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4. Discussion
AKs are one of the most common skin conditions in the elderly population, mainly
arising on sun-exposed areas of the skin in the context of a field cancerization. Following the
current guidelines, all AKs should be treated, since it is not possible to predict which ones
will grow into an invasive SCC [29]. The type of treatment should be determined based
on the clinical features, the patients’ comorbidities and the previous therapies. Various
local and field treatments, including surgery, laser ablation, photodynamic therapy and
diverse topical treatments such as 5-fluorouracile, diclofenac, imiquimod and potassium
hydroxide, can be used. It is known that diagnosis and follow-up of AKs can be improved
by non-invasive diagnostic technologies such as RCM, OCT and LC-OCT, which provide
a painless bedside examination of keratinocyte cancer (KC) [12,15,24,25,30–33]. RCM has
been used for grading increasing keratinocyte dysplasia into different levels, with good
correlation with histopathology, but it does not refer to specific classification systems [23].
We therefore focused on the in-vivo evaluation of the growth pattern of basal ker-
atinocytes through LC-OCT, based on the recent PRO classification. The latter proved, in
fact, to ensure the best interobserver agreement and the best risk stratification (in terms
of progression risk to SCC) compared to other AK classifications [19–21]. We chose to
use LC-OCT since it delivers dermoscopy-guided and real-time cross-sectional imaging
of skin lesions with cellular resolution, so that the cytological and architectural features
of the epidermis can be displayed in real time. It can visualize the epidermal layers, the
DEJ and the superficial dermis, and its vertical acquisitions can be intuitively compared to
histological slides [30,34,35]. Moreover, additional features such as perifollicular prolifera-
tion and adnexal extension can be visible, up to a depth of 500 µm. A direct and practical
consequence is the potential in-vivo assessment of AK progression risk, since PRO III AKs
are associated with a higher risk of developing an invasive SCC co pared to PRO I [19–21].
In our study, we were able to visualize and grade the downward extension of AKs non-
invasively through LC-OCT, defining key ima ing patterns that can be used as reference
images. We reported strong interobserver agreement in grading the basal growth pattern
of keratinocytes in the examined AKs. Moreover, we reported good ag eement in the PRO
classification of AKs between LC-OCT and traditional histopathology. Additionally, we
r a hed n overall agreemen f 85.4% when comparing the subgroup of PRO I and the
subgroup of PRO II/III AKs, which are the lesions at higher risk of progression to SCC
compared to PRO I.
LC-OCT displays the protrusions of atypical basal keratinocytes into the upper dermis
(spikes) and allows the measurement of their thickness compared to the overlying epider-
mis. This visual evaluation permits a reproducible LC-OCT grading of AKs based on the
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PRO histological classification. We were able to classify PRO I as lesions with no visible
spikes, PRO II as lesions with spikes slightly protruding into the papillary dermis and PRO
III as lesions with more prominent spikes, thicker than the overlying epidermis (Figure 1,
Figure 5). Our criteria can be used as a reference model for LC-OCT grading of AKs. The
high reproducibility (90%) between observers demonstrates that skilled imaging experts
are able to perform an in-vivo evaluation of cyto-architectural atypia with LC-OCT.
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Figure 5. LC-OCT vertical (A), 3D (B,C) and dermoscopy (D) of a pigmented PRO III AK lesion on the dorsum of the hand
of an 82-year-old male patient. The typical papillary sprouting as well as the pigmented basal keratinocytes are visible.
LC-OCT can be therefore considered a useful tool for the diagnosis and therapeutic
monitoring of AKs and might be successfully used in both clinical trials and daily routine.
As OCT and RCM, it can be used for a live, in-vivo mapping of several lesions in different
progression stages and perilesional skin in the context of field cancerization, avoiding
multiple surgical biopsies and related consequences (pain, discomfort, scars, inflammatory
reactions, failed localization). Compared to conventional OCT, LC-OCT has a higher
resolution and allows the assessment of cytological features and not only structural details.
Compared to RCM, LC-OCT displays vertical sections simultaneously to horizontal slides
as in RCM. Thus, it is much easier in LC-OCT images to determine the degree of basal
proliferation and compare it with histology.
Some limitations have to be taken into account. In our study, two large and thick
hyperkeratotic lesions were not fully evaluable. This sheds light on the good but still not
perfect penetration depth of the LC-OCT, which does not fully display the basal layer in
the presence of severe hyperkeratosis. In such cases, it is useful to examine the margins
of the lesion, since the basal growth pattern of keratinocytes does not depend on the
lesion thickness. Moreover, in this regard, it was easier for the observers to evaluate the
downward growth pattern of basal keratinocytes in the context of a PRO classification,
compared to the distribution of the atypical keratinocytes through the epidermis, as in
other classifications. Another limitation of the study was the small sample size (50 lesions,
belonging to 43 patients). Since some lesions arose on the same patient, a bias derived from
this aspect cannot be excluded; however, we only included independent lesions, arising on
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different anatomical sites and separately imaged and biopsied, so that we considered the
number of cases acceptable for a lesion-centered, pilot study [36]. An additional, crucial
point that has to be taken into account is represented by the observer´s experience, not
only in non-invasive diagnostic techniques but also in dermatopathology. All observers
in this study had knowledge of dermatopathology and non-invasive imaging; it was not
possible to perform a correlation of the LC-OCT grading and the level of experience of the
observer.
The agreement between LC-OCT and histology was lower in PRO I compared to PRO
II/III, due to overestimation. Five cases graded as PRO I in histology were evaluated as
PRO II/III with LC-OCT. This might be due to confounders such as hair follicles and shafts,
which might appear as longitudinal structures in the sections, but also to the larger field
of view, providing a global analysis of the examined area. LC-OCT can, in fact, scan the
whole AK lesion in a three-dimensional way, guided by a camera, displaying multiple
scans; on the contrary, the pathologist only has a few histological sections at their disposal,
since only a few slides are obtained from each tissue block in the daily diagnostic routine.
From this perspective, LC-OCT might provide additional details regarding non-invasive
AK grading, correctly directing lesions to either conservative or surgical therapy based on
their basal growth pattern.
5. Conclusions
LC-OCT is able to perform a reliable in-vivo evaluation of basal keratinocyte growth
pattern based on the histopathological PRO classification of AKs, with strong agreement
with histopathology and between different observers. Larger studies, also potentially aided
by artificial intelligence algorithms, are needed to validate the method.
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